Columbia University Division of Pediatric Oncology Chooses Millennium Biotechnologies' Resurgex Select(R) for Multi-Site Clinical Trial
03. März 2010 08:30 ET
|
Inergetics, Inc.
PARAMUS, N.J., March 3, 2010 (GLOBE NEWSWIRE) -- Millennium Biotechnologies Group Inc. (OTCBB:MBTG), a leader in the development of targeted nutritional products in the Clinical Nutrition Market and...